Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(03): 143-144
DOI: 10.4103/2278-330X.136752
MINI SYMPOSIUM: HEAD AND NECK CANCER : Editorial

Head and neck cancers: Safely preserving the talk

Anusheel Munshi
Senior Consultant, Radiation Oncology, Fortis Memorial Research Institute, Sector 44, Gurgaon, India
› Author Affiliations
Source of Support: Nill.
› Further Information
Also available at
 PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Lasrado S, Moras K, Pinto GJ, Bhat M, Hegde S, Sathian B, et al. Role of concomitant chemoradiation in locally advanced head and neck cancers. Asian Pac J Cancer Prev 2014;15:4147-52.
  • 2 Overgaard J, Mohanti BK, Begum N, Ali R, Agarwal JP, Kuddu M, et al. Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): A randomised, multicentre trial. Lancet Oncol 2010;11:553-60.
  • 3 Minicucci EM, da Silva GN, Salvadori DM. Relationship between head and neck cancer therapy and some genetic endpoints. World J Clin Oncol 2014;5:93-102.
  • 4 Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The "New" Head and Neck Cancer Patient-Young, Nonsmoker, Nondrinker, and HPV Positive: Evaluation. Otolaryngol Head Neck Surg 2014 Jun 12. [Epub ahead of print].
  • 5 Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-90.
  • 6 Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 1996;88:890-9.
  • 7 Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site. Radiother Oncol 2011;100:33-40.
  • 8 Dandekar M, D′Cruz A. Organ preservation strategies: Review of literature and their applicability in developing nations. South Asian J Cancer 2014;3:147-50.
  • 9 Munshi A, Pandey MB, Durga T, Pandey KC, Bahadur S, Mohanti BK. Weight loss during radiotherapy for head and neck malignancies: What factors impact it? Nutr Cancer 2003;47:136-40.
  • 10 Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, et al. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): An open-label phase 3 randomised trial. Lancet Oncol 2012;13:145-53.
  • 11 Morato-Galán M, Caminero Cueva MJ, Rodrigo JP, Suárez Nieto C, Núñez-Batalla F. Assessment of vocal quality following treatment of advanced pharyngo-laryngeal carcinoma with a protocol of organ preservation. Acta Otorrinolaringol Esp. 2014 Feb 27. [Epub ahead of print].
  • 12 Munshi A, Agarwal JP. Evolution of radiation oncology: Sharp gun, but a blurred target. J Cancer Res Ther 2010;6:3-4.
  • 13 Haddad R, O′Neill A, Rabinowits G, Tishler R, Khuri F, Adkins D, et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): A randomised phase 3 trial. Lancet Oncol 2013;14:257-64.
  • 14 Kunieda F, Kiyota N, Tahara M, Kodaira T, Hayashi R, Ishikura S, et al. Randomized phase II/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck: Japan clinical oncology group study (JCOG1008). Jpn J Clin Oncol 2014 May 19. [Epub ahead of print].